Mahidol Oxford Tropical Medicine Research Unit (MORU)

Mahidol Oxford Tropical Medicine Research Unit (MORU)

Consultation date: 19 January 2015

Malaria elimination strategy

The Mahidol Oxford Tropical Medicine Research Unit (MORU) was established in 1979 as a research collaboration between Mahidol University (Thailand), University of Oxford (UK) and the UK’s Wellcome Trust. MORU receives core funding from the Wellcome Trust.

MORU develops effective and practical means of diagnosing and treating malaria and other neglected diseases. Most of the research conducted at MORU is based in Asia.

Malaria research at MORU aims to elucidate knowledge on the treatment of malaria, mechanisms and spread of antimalarial drug resistance, and the pathophysiology of falciparum and vivax malaria. Over the past years, MORU has focused on understanding the importance of subclinical P. falciparum infections and investigating how these infections should be managed. MORU conducts research in close collaboration with the Cambodia National Malaria Center (CNM).



Leading 13 project(s)

May 2011 to Dec 2014

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria